Yarrow Bioscience, Inc. is a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases. The company is developing YB-101, a potentially first-of-its-kind antibody therapy aimed at treating Graves disease (GD) and thyroid eye disease (TED). Yarrow Bioscience was founded in October 2025 and is headquartered in New Haven, CT.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
10
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Yarrow Bioscience Inc. market cap is $170.16M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Yarrow Bioscience Inc. 52 week high is $44.28 as of November 17, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Yarrow Bioscience Inc. 52 week low is $9.65 as of November 17, 2026.
Yarrow Bioscience Inc. stock price today is $13.93.
Yarrow Bioscience Inc. stock price yesterday was $18.03.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Yarrow Bioscience Inc.'s P/E ratio is -0.91.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Yarrow Bioscience Inc. P/B ratio is 0.5974.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Yarrow Bioscience Inc. 50-day moving average is $21.55.